Effects of angiotensin II and 1-sar., 8-isoleu. angiotensin II on electrical and mechanical properties of the portal vein from rats of different ages. 1979

Y Takata, and H Kuriyama

The effects of angiotensin II (Ag-11) and 1-sar., 8-isoleu. angiotensin 11 (anti-Ag-11) on the membrane and mechanical properties of smooth muscle cells of the rat portal vein were investigated in three different age groups (6--8 weeks, immature rat; 3--5 months old, young rat and 13--15 months old, adult rat). Application of Ag-11 (10(-10) g/ml) did not depolarize the membrane, but did increase the spike frequency and potentiated the frequency and amplitude of twitch contraction. In a concentration of more than 10(-9) g/ml Ag-II, the membrane was depolarized and a phasic contracture was developed in three age groups. Depolarization of the membrane produced by Ag-II could be classified into two components, i.e. phasic and tonic depolarizations. In adult rats, Ag-II produced the highest amplitude of the depolarization in three age groups but tonic depolarization showed nearly the same amplitude of smooth muscle cell membrane to Ag-II increases with age up to 3--5 months and that an increased sensitivity is accompanied by a generation of desensitization. Tachyphylaxis to Ag-II was also observed by repetitive applications, but the appearance depended on the stimulus conditions. Anti-Ag-II, itself slightly increased the spike frequency and the amplitude of twitch contraction. However, under pretreatment with anti-Ag-II (10(-9) or 10(-7) g/ml), the actions of Ag-II on the electrical and mechanical activities were markedly suppressed in the three age groups. When the dose-response curve was obtained from the mechanical response produced by Ag-II, the relation shifted to the right in the presence of anti-Ag-II in all age groups. In the presence of 10(-7) g/ml anti-Ag-II, no contracture was evoked by application of 10(-6) g/ml Ag-II in three age groups. Anti-Ag-II seems to possess a higher affinity to the angiotensin receptor than does Ag-II.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Takata, and H Kuriyama
December 1977, European journal of clinical investigation,
Y Takata, and H Kuriyama
January 1979, Minerva nefrologica,
Y Takata, and H Kuriyama
February 1979, Archives internationales de physiologie et de biochimie,
Y Takata, and H Kuriyama
January 1977, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
Y Takata, and H Kuriyama
January 1978, Clinical and experimental pharmacology & physiology,
Y Takata, and H Kuriyama
January 1978, Contributions to nephrology,
Y Takata, and H Kuriyama
July 1981, Pflugers Archiv : European journal of physiology,
Y Takata, and H Kuriyama
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!